852 related articles for article (PubMed ID: 28483841)
1. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
[TBL] [Abstract][Full Text] [Related]
3. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
[TBL] [Abstract][Full Text] [Related]
4. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
[TBL] [Abstract][Full Text] [Related]
5. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
Lue LF; Schmitz C; Walker DG
Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
[TBL] [Abstract][Full Text] [Related]
7. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
[TBL] [Abstract][Full Text] [Related]
8. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
9. Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism.
Götzl JK; Brendel M; Werner G; Parhizkar S; Sebastian Monasor L; Kleinberger G; Colombo AV; Deussing M; Wagner M; Winkelmann J; Diehl-Schmid J; Levin J; Fellerer K; Reifschneider A; Bultmann S; Bartenstein P; Rominger A; Tahirovic S; Smith ST; Madore C; Butovsky O; Capell A; Haass C
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31122931
[TBL] [Abstract][Full Text] [Related]
10. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.
Hall-Roberts H; Agarwal D; Obst J; Smith TB; Monzón-Sandoval J; Di Daniel E; Webber C; James WS; Mead E; Davis JB; Cowley SA
Alzheimers Res Ther; 2020 Nov; 12(1):151. PubMed ID: 33198789
[TBL] [Abstract][Full Text] [Related]
11. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
12. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
Qu W; Li L
Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
[TBL] [Abstract][Full Text] [Related]
13. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
14. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
[TBL] [Abstract][Full Text] [Related]
15. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.
Kleinberger G; Brendel M; Mracsko E; Wefers B; Groeneweg L; Xiang X; Focke C; Deußing M; Suárez-Calvet M; Mazaheri F; Parhizkar S; Pettkus N; Wurst W; Feederle R; Bartenstein P; Mueggler T; Arzberger T; Knuesel I; Rominger A; Haass C
EMBO J; 2017 Jul; 36(13):1837-1853. PubMed ID: 28559417
[TBL] [Abstract][Full Text] [Related]
16. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
[TBL] [Abstract][Full Text] [Related]
17. Activation of FAK/Rac1/Cdc42-GTPase signaling ameliorates impaired microglial migration response to Aβ
Rong Z; Cheng B; Zhong L; Ye X; Li X; Jia L; Li Y; Shue F; Wang N; Cheng Y; Huang X; Liu CC; Fryer JD; Wang X; Zhang YW; Zheng H
FASEB J; 2020 Aug; 34(8):10984-10997. PubMed ID: 32613609
[TBL] [Abstract][Full Text] [Related]
18. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
19. TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.
Xiang X; Werner G; Bohrmann B; Liesz A; Mazaheri F; Capell A; Feederle R; Knuesel I; Kleinberger G; Haass C
EMBO Mol Med; 2016 Sep; 8(9):992-1004. PubMed ID: 27402340
[TBL] [Abstract][Full Text] [Related]
20. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R
Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
